Cite
A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment.
MLA
Somoskovi, Akos, et al. “A Mutation Associated with Clofazimine and Bedaquiline Cross-Resistance in MDR-TB Following Bedaquiline Treatment.” The European Respiratory Journal, vol. 45, no. 2, Feb. 2015, pp. 554–57. EBSCOhost, https://doi.org/10.1183/09031936.00142914.
APA
Somoskovi, A., Bruderer, V., Hömke, R., Bloemberg, G. V., & Böttger, E. C. (2015). A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment. The European Respiratory Journal, 45(2), 554–557. https://doi.org/10.1183/09031936.00142914
Chicago
Somoskovi, Akos, Vera Bruderer, Rico Hömke, Guido V Bloemberg, and Erik C Böttger. 2015. “A Mutation Associated with Clofazimine and Bedaquiline Cross-Resistance in MDR-TB Following Bedaquiline Treatment.” The European Respiratory Journal 45 (2): 554–57. doi:10.1183/09031936.00142914.